Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells

Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

NCT06678724 ·Status: RECRUITING

Culture System for Isolating Circulating Tumor cells_2

NCT04125667 ·Status: UNKNOWN

Identification of Key Blood Molecular Markers for Immunotherapy

NCT00507702 ·Status: TERMINATED

Detecting EGFR T790M Mutations From Circulating Tumor Cells

NCT01734915 ·Status: COMPLETED

Collection of Blood Specimens for Circulating Tumor Cell Analysis

NCT01943500 ·Status: COMPLETED

Circulating Tumor Cells in Solid Tumors

NCT03161821 ·Status: COMPLETED

Circulating Tumor Cells (CTC) in Cancer

NCT04520672 ·Status: RECRUITING

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

NCT01433224 ·Status: COMPLETED

Collection of Blood From Patients With Cancer

NCT00034216 ·Status: RECRUITING

Investigation of Cancer Cell Extravasation Through mRNA Analysis of Organ-specific Endothelial Cells and Microfluidics

NCT04047459 ·Status: COMPLETED

Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer

NCT02904161 ·Status: COMPLETED

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

NCT02474160 ·Status: RECRUITING

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100 ·Status: COMPLETED

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204 ·Status: COMPLETED

Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

NCT06782451 ·Status: RECRUITING ·Phase: NA

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT05600933 ·Status: ENROLLING_BY_INVITATION

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

NCT02220556 ·Status: COMPLETED ·Phase: NA

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

NCT03189108 ·Status: TERMINATED

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 ·Status: RECRUITING

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

NCT00026663 ·Status: COMPLETED

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643 ·Status: RECRUITING

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

NCT00899782 ·Status: COMPLETED

Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

NCT01520246 ·Status: COMPLETED

Integrated Molecular Analysis of Cancer (IMAC)

NCT02078544 ·Status: UNKNOWN

Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer

NCT00898781 ·Status: TERMINATED